Mary Foster addresses many biopharmaceutical professional’s concern of how to apply the current GDP regulations to biologics and discusses the need for written regulations specific to biologics.
The U.S. is served by publicly - and privately-owned marine facilities located in approximately 360 commercial sea and river ports. These are found along the Atlantic, Pacific, Gulf and Great Lakes coasts, as well as in Alaska, Hawaii, Puerto Rico, Guam and the U.S. Virgin Islands.
Manufacturers and distributors, like companies in other industries, face mounting cybersecurity risks. Still, some don't do enough to address the issue and protect intellectual property and sensitive data and information, according to a new industry report from professional services firm Sikich LLP.
More organizations are investing in business-to-business electronic integration (B2Bi) to cut costs and increase business flow efficiency, according to a survey of more than 200 organizations by the University of Tennessee's Global Supply Chain Institute and integration provider DiCentral.
Last week, the Rolls-Royce led Advanced Autonomous Waterborne Applications Initiative (AAWA) project presented its first findings at a conference in Helsinki, expressing high hopes for vessel automation in commercial service -- and predicting that it will arrive soon.
Accountability - the ability of people to understand what is expected of them, exercise authority, and take responsibility for delivering results - is an important dimension of organizational health. Of course, some companies are better at fostering it than others.
A decade ago, consumers accepted waiting a week for their product but now with the infusion of companies such as Amazon and Alibaba, consumers are making their purchase decisions based on how quickly they will receive the product. In order to stay competitive in the marketplace, companies are turning to 3D printing to create their products quicker.
The world's farmers have increased their use of genetically modified crops steadily and sharply since the technology became broadly commercialized in 1996. Not anymore.
During the long downturn in R&D productivity, a handful of biopharmaceutical companies have consistently bucked the trend. How did they manage it? After all, they have experienced the same industry pressures as their peers - pressures such as lengthier R&D cycle times, higher costs of failure, and sharper regulatory scrutiny.
The latest supply-chain news, analysis, trends and tools for executives in the pharmaceutical and biotech industries. Learn how pharmaceutical and biotech companies and their suppliers around the world are managing the flow of products across all channels of the enterprise. Experts sound off on forecasting and demand planning, supply-chain visibility, logistics outsourcing, inventory optimization, transportation management, warehouse management, supply-chain security, corporate social responsibility and more.
Subscribe to our Daily Newsletter!
Timely, incisive articles delivered directly to your inbox.